img

Global Migraine Medication Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Migraine Medication Market Insights, Forecast to 2034

Migraine medication can provide headache relief for your pain. There are several types of migraine medications available, both over-the-counter (OTC) and prescription, that can help alleviate headache symptoms. The choice of medication depends on the type and severity of the headache, as well as other individual factors.
Market Analysis and InsightsGlobal Migraine Medication Market
Global Migraine Medication market is expected to reach to US$ 6108 million in 2024, with a positive growth of %, compared with US$ 5912 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Migraine Medication industry is evaluated to reach US$ 7335.9 million in 2029. The CAGR will be 3.1% during 2024 to 2029.
One of the primary market drivers for migraine medication is the high prevalence of headaches and migraines among the global population. Headaches are one of the most common medical complaints, affecting a significant number of individuals across different age groups and demographics. Migraines, in particular, can be debilitating and significantly impact a person's quality of life, leading to a higher demand for effective headache medications. Additionally, the increasing awareness and understanding of headaches and migraines have contributed to the growth of the headache medicine market. As people become more informed about these conditions and their treatment options, they are more likely to seek medical help and utilize headache medications.
Report Covers
This report presents an overview of global Migraine Medication market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Migraine Medication market with multiple angles. Items like regional revenue from 2018 to 2029 and companies’ revenue and gross margin from 2018 to 2024 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


GSK
Teva
Pfizer
Amgen
Viatris
Allergan
Grunenthal
Eli Lilly
Johnson & Johnson
Bayer
Haleon
Tongde Pharmacy
Huazhong Pharmaceutical
Weisen Pharmaceutical
DIAO GROUP
Jiheng Pharmaceutical
Dirui Pharmaceutical
Segment by Type
NSAIDs
Acetaminophen
Triptans
Others

Segment by Application


Drug Stores
Hospitals
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2029
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2029 globally
Chapter 5Product revenue analysis by application from 2018 to 2029 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2029 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product revenue analysis by type and application from 2018 to 2029 in Europe. Product revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product revenue analysis by type and application from 2018 to 2029 in China. Product revenue analysis of China from 2018 to 2029
Chapter 9Product revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Companies’ outline, covering company’s basic information, major business, Migraine Medication introduction, etc. Migraine Medication Revenue and Gross Margin of each company from 2018 to 2024
Chapter 12Mr Accuracy reports’s Conclusions of Migraine Medication
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Migraine Medication Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 NSAIDs
1.2.3 Acetaminophen
1.2.4 Triptans
1.2.5 Others
1.3 Market by Application
1.3.1 Global Migraine Medication Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Drug Stores
1.3.3 Hospitals
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Migraine Medication Market Perspective (2018-2029)
2.2 Global Migraine Medication Growth Trends by Region
2.2.1 Migraine Medication Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Migraine Medication Historic Market Size by Region (2018-2024)
2.2.3 Migraine Medication Forecasted Market Size by Region (2024-2029)
2.3 Migraine Medication Market Dynamics
2.3.1 Migraine Medication Industry Trends
2.3.2 Migraine Medication Market Drivers
2.3.3 Migraine Medication Market Challenges
2.3.4 Migraine Medication Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Migraine Medication by Players
3.1.1 Global Migraine Medication Revenue by Players (2018-2024)
3.1.2 Global Migraine Medication Revenue Market Share by Players (2018-2024)
3.2 Global Migraine Medication Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Migraine Medication, Ranking by Revenue, 2021 VS 2022 VS 2024
3.4 Global Migraine Medication Market Concentration Ratio
3.4.1 Global Migraine Medication Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Migraine Medication Revenue in 2022
3.5 Global Key Players of Migraine Medication Head office and Area Served
3.6 Global Key Players of Migraine Medication, Product and Application
3.7 Global Key Players of Migraine Medication, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Migraine Medication Breakdown Data by Type
4.1 Global Migraine Medication Historic Market Size by Type (2018-2024)
4.2 Global Migraine Medication Forecasted Market Size by Type (2024-2029)
5 Migraine Medication Breakdown Data by Application
5.1 Global Migraine Medication Historic Market Size by Application (2018-2024)
5.2 Global Migraine Medication Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Migraine Medication Market Size (2018-2029)
6.2 North America Migraine Medication Market Size by Type
6.2.1 North America Migraine Medication Market Size by Type (2018-2024)
6.2.2 North America Migraine Medication Market Size by Type (2024-2029)
6.2.3 North America Migraine Medication Market Share by Type (2018-2029)
6.3 North America Migraine Medication Market Size by Application
6.3.1 North America Migraine Medication Market Size by Application (2018-2024)
6.3.2 North America Migraine Medication Market Size by Application (2024-2029)
6.3.3 North America Migraine Medication Market Share by Application (2018-2029)
6.4 North America Migraine Medication Market Size by Country
6.4.1 North America Migraine Medication Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Migraine Medication Market Size by Country (2018-2024)
6.4.3 North America Migraine Medication Market Size by Country (2024-2029)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Migraine Medication Market Size (2018-2029)
7.2 Europe Migraine Medication Market Size by Type
7.2.1 Europe Migraine Medication Market Size by Type (2018-2024)
7.2.2 Europe Migraine Medication Market Size by Type (2024-2029)
7.2.3 Europe Migraine Medication Market Share by Type (2018-2029)
7.3 Europe Migraine Medication Market Size by Application
7.3.1 Europe Migraine Medication Market Size by Application (2018-2024)
7.3.2 Europe Migraine Medication Market Size by Application (2024-2029)
7.3.3 Europe Migraine Medication Market Share by Application (2018-2029)
7.4 Europe Migraine Medication Market Size by Country
7.4.1 Europe Migraine Medication Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Migraine Medication Market Size by Country (2018-2024)
7.4.3 Europe Migraine Medication Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Migraine Medication Market Size (2018-2029)
8.2 China Migraine Medication Market Size by Type
8.2.1 China Migraine Medication Market Size by Type (2018-2024)
8.2.2 China Migraine Medication Market Size by Type (2024-2029)
8.2.3 China Migraine Medication Market Share by Type (2018-2029)
8.3 China Migraine Medication Market Size by Application
8.3.1 China Migraine Medication Market Size by Application (2018-2024)
8.3.2 China Migraine Medication Market Size by Application (2024-2029)
8.3.3 China Migraine Medication Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Migraine Medication Market Size (2018-2029)
9.2 Asia Migraine Medication Market Size by Type
9.2.1 Asia Migraine Medication Market Size by Type (2018-2024)
9.2.2 Asia Migraine Medication Market Size by Type (2024-2029)
9.2.3 Asia Migraine Medication Market Share by Type (2018-2029)
9.3 Asia Migraine Medication Market Size by Application
9.3.1 Asia Migraine Medication Market Size by Application (2018-2024)
9.3.2 Asia Migraine Medication Market Size by Application (2024-2029)
9.3.3 Asia Migraine Medication Market Share by Application (2018-2029)
9.4 Asia Migraine Medication Market Size by Region
9.4.1 Asia Migraine Medication Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Migraine Medication Market Size by Region (2018-2024)
9.4.3 Asia Migraine Medication Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Migraine Medication Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Migraine Medication Market Size by Type
10.2.1 Middle East, Africa, and Latin America Migraine Medication Market Size by Type (2018-2024)
10.2.2 Middle East, Africa, and Latin America Migraine Medication Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Migraine Medication Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Migraine Medication Market Size by Application
10.3.1 Middle East, Africa, and Latin America Migraine Medication Market Size by Application (2018-2024)
10.3.2 Middle East, Africa, and Latin America Migraine Medication Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Migraine Medication Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Migraine Medication Market Size by Country
10.4.1 Middle East, Africa, and Latin America Migraine Medication Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Migraine Medication Market Size by Country (2018-2024)
10.4.3 Middle East, Africa, and Latin America Migraine Medication Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 GSK
11.1.1 GSK Company Details
11.1.2 GSK Business Overview
11.1.3 GSK Migraine Medication Introduction
11.1.4 GSK Revenue in Migraine Medication Business (2018-2024)
11.1.5 GSK Recent Developments
11.2 Teva
11.2.1 Teva Company Details
11.2.2 Teva Business Overview
11.2.3 Teva Migraine Medication Introduction
11.2.4 Teva Revenue in Migraine Medication Business (2018-2024)
11.2.5 Teva Recent Developments
11.3 Pfizer
11.3.1 Pfizer Company Details
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Migraine Medication Introduction
11.3.4 Pfizer Revenue in Migraine Medication Business (2018-2024)
11.3.5 Pfizer Recent Developments
11.4 Amgen
11.4.1 Amgen Company Details
11.4.2 Amgen Business Overview
11.4.3 Amgen Migraine Medication Introduction
11.4.4 Amgen Revenue in Migraine Medication Business (2018-2024)
11.4.5 Amgen Recent Developments
11.5 Viatris
11.5.1 Viatris Company Details
11.5.2 Viatris Business Overview
11.5.3 Viatris Migraine Medication Introduction
11.5.4 Viatris Revenue in Migraine Medication Business (2018-2024)
11.5.5 Viatris Recent Developments
11.6 Allergan
11.6.1 Allergan Company Details
11.6.2 Allergan Business Overview
11.6.3 Allergan Migraine Medication Introduction
11.6.4 Allergan Revenue in Migraine Medication Business (2018-2024)
11.6.5 Allergan Recent Developments
11.7 Grunenthal
11.7.1 Grunenthal Company Details
11.7.2 Grunenthal Business Overview
11.7.3 Grunenthal Migraine Medication Introduction
11.7.4 Grunenthal Revenue in Migraine Medication Business (2018-2024)
11.7.5 Grunenthal Recent Developments
11.8 Eli Lilly
11.8.1 Eli Lilly Company Details
11.8.2 Eli Lilly Business Overview
11.8.3 Eli Lilly Migraine Medication Introduction
11.8.4 Eli Lilly Revenue in Migraine Medication Business (2018-2024)
11.8.5 Eli Lilly Recent Developments
11.9 Johnson & Johnson
11.9.1 Johnson & Johnson Company Details
11.9.2 Johnson & Johnson Business Overview
11.9.3 Johnson & Johnson Migraine Medication Introduction
11.9.4 Johnson & Johnson Revenue in Migraine Medication Business (2018-2024)
11.9.5 Johnson & Johnson Recent Developments
11.10 Bayer
11.10.1 Bayer Company Details
11.10.2 Bayer Business Overview
11.10.3 Bayer Migraine Medication Introduction
11.10.4 Bayer Revenue in Migraine Medication Business (2018-2024)
11.10.5 Bayer Recent Developments
11.11 Haleon
11.11.1 Haleon Company Details
11.11.2 Haleon Business Overview
11.11.3 Haleon Migraine Medication Introduction
11.11.4 Haleon Revenue in Migraine Medication Business (2018-2024)
11.11.5 Haleon Recent Developments
11.12 Tongde Pharmacy
11.12.1 Tongde Pharmacy Company Details
11.12.2 Tongde Pharmacy Business Overview
11.12.3 Tongde Pharmacy Migraine Medication Introduction
11.12.4 Tongde Pharmacy Revenue in Migraine Medication Business (2018-2024)
11.12.5 Tongde Pharmacy Recent Developments
11.13 Huazhong Pharmaceutical
11.13.1 Huazhong Pharmaceutical Company Details
11.13.2 Huazhong Pharmaceutical Business Overview
11.13.3 Huazhong Pharmaceutical Migraine Medication Introduction
11.13.4 Huazhong Pharmaceutical Revenue in Migraine Medication Business (2018-2024)
11.13.5 Huazhong Pharmaceutical Recent Developments
11.14 Weisen Pharmaceutical
11.14.1 Weisen Pharmaceutical Company Details
11.14.2 Weisen Pharmaceutical Business Overview
11.14.3 Weisen Pharmaceutical Migraine Medication Introduction
11.14.4 Weisen Pharmaceutical Revenue in Migraine Medication Business (2018-2024)
11.14.5 Weisen Pharmaceutical Recent Developments
11.15 DIAO GROUP
11.15.1 DIAO GROUP Company Details
11.15.2 DIAO GROUP Business Overview
11.15.3 DIAO GROUP Migraine Medication Introduction
11.15.4 DIAO GROUP Revenue in Migraine Medication Business (2018-2024)
11.15.5 DIAO GROUP Recent Developments
11.16 Jiheng Pharmaceutical
11.16.1 Jiheng Pharmaceutical Company Details
11.16.2 Jiheng Pharmaceutical Business Overview
11.16.3 Jiheng Pharmaceutical Migraine Medication Introduction
11.16.4 Jiheng Pharmaceutical Revenue in Migraine Medication Business (2018-2024)
11.16.5 Jiheng Pharmaceutical Recent Developments
11.17 Dirui Pharmaceutical
11.17.1 Dirui Pharmaceutical Company Details
11.17.2 Dirui Pharmaceutical Business Overview
11.17.3 Dirui Pharmaceutical Migraine Medication Introduction
11.17.4 Dirui Pharmaceutical Revenue in Migraine Medication Business (2018-2024)
11.17.5 Dirui Pharmaceutical Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Migraine Medication Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of NSAIDs
Table 3. Key Players of Acetaminophen
Table 4. Key Players of Triptans
Table 5. Key Players of Others
Table 6. Global Migraine Medication Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 7. Global Migraine Medication Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 8. Global Migraine Medication Market Size by Region (2018-2024) & (US$ Million)
Table 9. Global Migraine Medication Market Share by Region (2018-2024)
Table 10. Global Migraine Medication Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 11. Global Migraine Medication Market Share by Region (2024-2029)
Table 12. Migraine Medication Market Trends
Table 13. Migraine Medication Market Drivers
Table 14. Migraine Medication Market Challenges
Table 15. Migraine Medication Market Restraints
Table 16. Global Migraine Medication Revenue by Players (2018-2024) & (US$ Million)
Table 17. Global Migraine Medication Revenue Share by Players (2018-2024)
Table 18. Global Top Migraine Medication by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Migraine Medication as of 2022)
Table 19. Global Migraine Medication Industry Ranking 2021 VS 2022 VS 2024
Table 20. Global 5 Largest Players Market Share by Migraine Medication Revenue (CR5 and HHI) & (2018-2024)
Table 21. Global Key Players of Migraine Medication, Headquarters and Area Served
Table 22. Global Key Players of Migraine Medication, Product and Application
Table 23. Global Key Players of Migraine Medication, Product and Application
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Migraine Medication Market Size by Type (2018-2024) & (US$ Million)
Table 26. Global Migraine Medication Revenue Market Share by Type (2018-2024)
Table 27. Global Migraine Medication Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 28. Global Migraine Medication Revenue Market Share by Type (2024-2029)
Table 29. Global Migraine Medication Market Size by Application (2018-2024) & (US$ Million)
Table 30. Global Migraine Medication Revenue Share by Application (2018-2024)
Table 31. Global Migraine Medication Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 32. Global Migraine Medication Revenue Share by Application (2024-2029)
Table 33. North America Migraine Medication Market Size by Type (2018-2024) & (US$ Million)
Table 34. North America Migraine Medication Market Size by Type (2024-2029) & (US$ Million)
Table 35. North America Migraine Medication Market Size by Application (2018-2024) & (US$ Million)
Table 36. North America Migraine Medication Market Size by Application (2024-2029) & (US$ Million)
Table 37. North America Migraine Medication Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 38. North America Migraine Medication Market Size by Country (2018-2024) & (US$ Million)
Table 39. North America Migraine Medication Market Size by Country (2024-2029) & (US$ Million)
Table 40. Europe Migraine Medication Market Size by Type (2018-2024) & (US$ Million)
Table 41. Europe Migraine Medication Market Size by Type (2024-2029) & (US$ Million)
Table 42. Europe Migraine Medication Market Size by Application (2018-2024) & (US$ Million)
Table 43. Europe Migraine Medication Market Size by Application (2024-2029) & (US$ Million)
Table 44. Europe Migraine Medication Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 45. Europe Migraine Medication Market Size by Country (2018-2024) & (US$ Million)
Table 46. Europe Migraine Medication Market Size by Country (2024-2029) & (US$ Million)
Table 47. China Migraine Medication Market Size by Type (2018-2024) & (US$ Million)
Table 48. China Migraine Medication Market Size by Type (2024-2029) & (US$ Million)
Table 49. China Migraine Medication Market Size by Application (2018-2024) & (US$ Million)
Table 50. China Migraine Medication Market Size by Application (2024-2029) & (US$ Million)
Table 51. Asia Migraine Medication Market Size by Type (2018-2024) & (US$ Million)
Table 52. Asia Migraine Medication Market Size by Type (2024-2029) & (US$ Million)
Table 53. Asia Migraine Medication Market Size by Application (2018-2024) & (US$ Million)
Table 54. Asia Migraine Medication Market Size by Application (2024-2029) & (US$ Million)
Table 55. Asia Migraine Medication Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 56. Asia Migraine Medication Market Size by Region (2018-2024) & (US$ Million)
Table 57. Asia Migraine Medication Market Size by Region (2024-2029) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Migraine Medication Market Size by Type (2018-2024) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Migraine Medication Market Size by Type (2024-2029) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Migraine Medication Market Size by Application (2018-2024) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Migraine Medication Market Size by Application (2024-2029) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Migraine Medication Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 63. Middle East, Africa, and Latin America Migraine Medication Market Size by Country (2018-2024) & (US$ Million)
Table 64. Middle East, Africa, and Latin America Migraine Medication Market Size by Country (2024-2029) & (US$ Million)
Table 65. GSK Company Details
Table 66. GSK Business Overview
Table 67. GSK Migraine Medication Product
Table 68. GSK Revenue in Migraine Medication Business (2018-2024) & (US$ Million)
Table 69. GSK Recent Developments
Table 70. Teva Company Details
Table 71. Teva Business Overview
Table 72. Teva Migraine Medication Product
Table 73. Teva Revenue in Migraine Medication Business (2018-2024) & (US$ Million)
Table 74. Teva Recent Developments
Table 75. Pfizer Company Details
Table 76. Pfizer Business Overview
Table 77. Pfizer Migraine Medication Product
Table 78. Pfizer Revenue in Migraine Medication Business (2018-2024) & (US$ Million)
Table 79. Pfizer Recent Developments
Table 80. Amgen Company Details
Table 81. Amgen Business Overview
Table 82. Amgen Migraine Medication Product
Table 83. Amgen Revenue in Migraine Medication Business (2018-2024) & (US$ Million)
Table 84. Amgen Recent Developments
Table 85. Viatris Company Details
Table 86. Viatris Business Overview
Table 87. Viatris Migraine Medication Product
Table 88. Viatris Revenue in Migraine Medication Business (2018-2024) & (US$ Million)
Table 89. Viatris Recent Developments
Table 90. Allergan Company Details
Table 91. Allergan Business Overview
Table 92. Allergan Migraine Medication Product
Table 93. Allergan Revenue in Migraine Medication Business (2018-2024) & (US$ Million)
Table 94. Allergan Recent Developments
Table 95. Grunenthal Company Details
Table 96. Grunenthal Business Overview
Table 97. Grunenthal Migraine Medication Product
Table 98. Grunenthal Revenue in Migraine Medication Business (2018-2024) & (US$ Million)
Table 99. Grunenthal Recent Developments
Table 100. Eli Lilly Company Details
Table 101. Eli Lilly Business Overview
Table 102. Eli Lilly Migraine Medication Product
Table 103. Eli Lilly Revenue in Migraine Medication Business (2018-2024) & (US$ Million)
Table 104. Eli Lilly Recent Developments
Table 105. Johnson & Johnson Company Details
Table 106. Johnson & Johnson Business Overview
Table 107. Johnson & Johnson Migraine Medication Product
Table 108. Johnson & Johnson Revenue in Migraine Medication Business (2018-2024) & (US$ Million)
Table 109. Johnson & Johnson Recent Developments
Table 110. Bayer Company Details
Table 111. Bayer Business Overview
Table 112. Bayer Migraine Medication Product
Table 113. Bayer Revenue in Migraine Medication Business (2018-2024) & (US$ Million)
Table 114. Bayer Recent Developments
Table 115. Haleon Company Details
Table 116. Haleon Business Overview
Table 117. Haleon Migraine Medication Product
Table 118. Haleon Revenue in Migraine Medication Business (2018-2024) & (US$ Million)
Table 119. Haleon Recent Developments
Table 120. Tongde Pharmacy Company Details
Table 121. Tongde Pharmacy Business Overview
Table 122. Tongde Pharmacy Migraine Medication Product
Table 123. Tongde Pharmacy Revenue in Migraine Medication Business (2018-2024) & (US$ Million)
Table 124. Tongde Pharmacy Recent Developments
Table 125. Huazhong Pharmaceutical Company Details
Table 126. Huazhong Pharmaceutical Business Overview
Table 127. Huazhong Pharmaceutical Migraine Medication Product
Table 128. Huazhong Pharmaceutical Revenue in Migraine Medication Business (2018-2024) & (US$ Million)
Table 129. Huazhong Pharmaceutical Recent Developments
Table 130. Weisen Pharmaceutical Company Details
Table 131. Weisen Pharmaceutical Business Overview
Table 132. Weisen Pharmaceutical Migraine Medication Product
Table 133. Weisen Pharmaceutical Revenue in Migraine Medication Business (2018-2024) & (US$ Million)
Table 134. Weisen Pharmaceutical Recent Developments
Table 135. DIAO GROUP Company Details
Table 136. DIAO GROUP Business Overview
Table 137. DIAO GROUP Migraine Medication Product
Table 138. DIAO GROUP Revenue in Migraine Medication Business (2018-2024) & (US$ Million)
Table 139. DIAO GROUP Recent Developments
Table 140. Jiheng Pharmaceutical Company Details
Table 141. Jiheng Pharmaceutical Business Overview
Table 142. Jiheng Pharmaceutical Migraine Medication Product
Table 143. Jiheng Pharmaceutical Revenue in Migraine Medication Business (2018-2024) & (US$ Million)
Table 144. Jiheng Pharmaceutical Recent Developments
Table 145. Dirui Pharmaceutical Company Details
Table 146. Dirui Pharmaceutical Business Overview
Table 147. Dirui Pharmaceutical Migraine Medication Product
Table 148. Dirui Pharmaceutical Revenue in Migraine Medication Business (2018-2024) & (US$ Million)
Table 149. Dirui Pharmaceutical Recent Developments
Table 150. Research Programs/Design for This Report
Table 151. Key Data Information from Secondary Sources
Table 152. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Migraine Medication Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global Migraine Medication Market Share by Type: 2022 VS 2029
Figure 3. NSAIDs Features
Figure 4. Acetaminophen Features
Figure 5. Triptans Features
Figure 6. Others Features
Figure 7. Global Migraine Medication Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 8. Global Migraine Medication Market Share by Application: 2022 VS 2029
Figure 9. Drug Stores Case Studies
Figure 10. Hospitals Case Studies
Figure 11. Others Case Studies
Figure 12. Migraine Medication Report Years Considered
Figure 13. Global Migraine Medication Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 14. Global Migraine Medication Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global Migraine Medication Market Share by Region: 2022 VS 2029
Figure 16. Global Migraine Medication Market Share by Players in 2022
Figure 17. Global Top Migraine Medication Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Migraine Medication as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Migraine Medication Revenue in 2022
Figure 19. North America Migraine Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. North America Migraine Medication Market Share by Type (2018-2029)
Figure 21. North America Migraine Medication Market Share by Application (2018-2029)
Figure 22. North America Migraine Medication Market Share by Country (2018-2029)
Figure 23. United States Migraine Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Canada Migraine Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Europe Migraine Medication Market Size YoY (2018-2029) & (US$ Million)
Figure 26. Europe Migraine Medication Market Share by Type (2018-2029)
Figure 27. Europe Migraine Medication Market Share by Application (2018-2029)
Figure 28. Europe Migraine Medication Market Share by Country (2018-2029)
Figure 29. Germany Migraine Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. France Migraine Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. U.K. Migraine Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Italy Migraine Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Russia Migraine Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Nordic Countries Migraine Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. China Migraine Medication Market Size YoY (2018-2029) & (US$ Million)
Figure 36. China Migraine Medication Market Share by Type (2018-2029)
Figure 37. China Migraine Medication Market Share by Application (2018-2029)
Figure 38. Asia Migraine Medication Market Size YoY (2018-2029) & (US$ Million)
Figure 39. Asia Migraine Medication Market Share by Type (2018-2029)
Figure 40. Asia Migraine Medication Market Share by Application (2018-2029)
Figure 41. Asia Migraine Medication Market Share by Region (2018-2029)
Figure 42. Japan Migraine Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. South Korea Migraine Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. China Taiwan Migraine Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Southeast Asia Migraine Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. India Migraine Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Australia Migraine Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Middle East, Africa, and Latin America Migraine Medication Market Size YoY (2018-2029) & (US$ Million)
Figure 49. Middle East, Africa, and Latin America Migraine Medication Market Share by Type (2018-2029)
Figure 50. Middle East, Africa, and Latin America Migraine Medication Market Share by Application (2018-2029)
Figure 51. Middle East, Africa, and Latin America Migraine Medication Market Share by Country (2018-2029)
Figure 52. Brazil Migraine Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 53. Mexico Migraine Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. Turkey Migraine Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. Saudi Arabia Migraine Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. Israel Migraine Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 57. GCC Countries Migraine Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 58. GSK Revenue Growth Rate in Migraine Medication Business (2018-2024)
Figure 59. Teva Revenue Growth Rate in Migraine Medication Business (2018-2024)
Figure 60. Pfizer Revenue Growth Rate in Migraine Medication Business (2018-2024)
Figure 61. Amgen Revenue Growth Rate in Migraine Medication Business (2018-2024)
Figure 62. Viatris Revenue Growth Rate in Migraine Medication Business (2018-2024)
Figure 63. Allergan Revenue Growth Rate in Migraine Medication Business (2018-2024)
Figure 64. Grunenthal Revenue Growth Rate in Migraine Medication Business (2018-2024)
Figure 65. Eli Lilly Revenue Growth Rate in Migraine Medication Business (2018-2024)
Figure 66. Johnson & Johnson Revenue Growth Rate in Migraine Medication Business (2018-2024)
Figure 67. Bayer Revenue Growth Rate in Migraine Medication Business (2018-2024)
Figure 68. Haleon Revenue Growth Rate in Migraine Medication Business (2018-2024)
Figure 69. Tongde Pharmacy Revenue Growth Rate in Migraine Medication Business (2018-2024)
Figure 70. Huazhong Pharmaceutical Revenue Growth Rate in Migraine Medication Business (2018-2024)
Figure 71. Weisen Pharmaceutical Revenue Growth Rate in Migraine Medication Business (2018-2024)
Figure 72. DIAO GROUP Revenue Growth Rate in Migraine Medication Business (2018-2024)
Figure 73. Jiheng Pharmaceutical Revenue Growth Rate in Migraine Medication Business (2018-2024)
Figure 74. Dirui Pharmaceutical Revenue Growth Rate in Migraine Medication Business (2018-2024)
Figure 75. Bottom-up and Top-down Approaches for This Report
Figure 76. Data Triangulation
Figure 77. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries